Spyre Therapeutics Cash Flow Statement (2015-2026) | SYRE

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-6.83M-20.31M-20.45M-24.44M-22.32M-18.23M-18.82M-18.42M-217.08M-40.11M-63.18M-43.86M-38.84M-69.03M-56.30M-44.77M-36.72M-11.18M-62.53M-69.00M
Share-based Compensation (Quarter)
2.08M2.11M2.09M2.10M2.02M1.43M1.70M1.90M4.80M17.27M13.80M8.70M13.10M9.22M8.86M9.38M9.57M9.81M12.81M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)
2.16M0.40M0.34M2.14M0.43M3.84M0.42M4.44M63.42M-0.91M-0.20M
Non-cash Items (Quarter)
0.33M0.00M
Cash from Operations (Quarter)
2.08M-17.00M-19.27M-26.26M-20.67M-15.07M-18.14M-17.63M-16.64M-34.60M-31.04M-28.54M-62.25M-29.42M-37.20M-40.99M-46.56M-37.12M-44.58M-57.37M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.16M-0.15M-0.06M-0.01M0.04M0.27M0.10M0.11M0.02M0.10M2.42M3.56M3.00M2.42M2.64M2.01M1.35M-6.00M2.06M
Depreciation & Amortization (CF) (Quarter)
0.40M0.41M0.41M0.40M0.38M0.40M0.39M0.38M0.36M
Change in Working Capital
Change in Receivables (Quarter)
-21.50M0.81M0.20M-0.53M0.19M-0.29M-0.04M1.32M-1.48M-0.16M
Change in Account Payables (Quarter)
0.32M-0.34M0.39M-0.34M-1.01M1.35M2.04M-4.16M2.33M2.21M0.12M1.93M-4.50M3.02M-3.60M7.36M-7.38M0.04M
Change in Accured Expenses (Quarter)
0.83M1.04M0.46M-3.14M2.26M-0.42M0.45M-3.16M2.11M-2.94M-0.89M8.15M-15.77M7.37M14.87M-6.00M-2.30M4.41M3.12M3.65M
Investing Activities
Capital Expenditures (Quarter)
-0.43M0.55M0.04M0.00M-2.07M
Sales of Property, Plant and Equipment (Quarter)
0.50M
Change in Intangibles (Quarter)
7.00M30.00M
Change in Acquisitions & Divestments (Quarter)
22.00M32.12M22.91M29.30M25.00M23.75M18.50M17.75M3.25M18.90M47.75M57.88M77.79M62.55M71.38M106.87M99.19M94.30M107.75M
Cash from Investing Activities (Quarter)
-47.36M5.78M9.66M25.76M0.75M16.50M14.00M17.75M6.76M-97.63M-35.27M-104.96M-120.52M42.74M-170.54M-0.06M79.00M25.00M-247.41M56.58M
Financing Activities
Other financing activities (Quarter)
2.08M2.11M2.09M2.10M2.02M1.57M1.43M1.71M1.77M
Change in Capital Stock
Shares Issued (Quarter)
0.04M1.25M-1.65M0.18M0.04M0.02M0.10M0.28M169.21M-164.32M163.97M-161.34M0.22M0.85M-1.07M3.31M2.68M
Preferred Shares Issued (Quarter)
210.00M-12.64M169.21M-169.21M
Misc.
Cash from Financing Activities (Quarter)
-0.19M1.14M0.08M0.01M42.80M-0.13M-0.01M0.01M209.99M-12.53M163.61M172.16M0.36M12.78M225.60M0.12M0.73M-4.64M312.81M12.26M
Exchange Rate Effect (Quarter)
0.00M-0.03M0.00M-0.02M-0.07M-0.06M0.05M0.01M0.01M-0.02M0.02M-0.00M0.02M-0.01M
Change in Cash (Quarter)
-45.47M-10.11M-9.52M-0.52M22.81M1.24M-4.10M0.14M200.12M-144.78M97.32M38.66M-182.41M26.11M17.84M-40.93M33.17M-16.76M20.82M11.46M
Free Cash Flow (Quarter)
2.51M-17.55M-19.27M-26.30M-20.67M-15.07M-18.14M-17.63M-16.64M-32.53M-31.04M-28.54M-62.25M-29.42M-37.20M-40.99M-46.56M-37.12M-44.58M-57.37M
Net Cash Flow (Quarter)
-45.47M-10.08M-9.53M-0.49M22.88M1.30M-4.15M0.13M200.11M-144.76M97.30M38.66M-182.41M26.10M17.86M-40.93M33.17M-16.76M20.82M11.46M